- Home
- INDV vs QQQX Comparison
INDV vs QQQX Comparison
Compare INDV & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDV
- QQQX
- Stock Information
- Founded
- INDV 1994
- QQQX 2007
- Country
- INDV United States
- QQQX United States
- Employees
- INDV N/A
- QQQX N/A
- Industry
- INDV Biotechnology: Pharmaceutical Preparations
- QQQX Finance Companies
- Sector
- INDV Health Care
- QQQX Finance
- Exchange
- INDV Nasdaq
- QQQX Nasdaq
- Market Cap
- INDV 1.4B
- QQQX 1.2B
- IPO Year
- INDV N/A
- QQQX N/A
- Fundamental
- Price
- INDV $12.46
- QQQX $25.38
- Analyst Decision
- INDV Strong Buy
- QQQX
- Analyst Count
- INDV 2
- QQQX 0
- Target Price
- INDV $14.50
- QQQX N/A
- AVG Volume (30 Days)
- INDV 905.8K
- QQQX 127.6K
- Earning Date
- INDV 07-24-2025
- QQQX 01-01-0001
- Dividend Yield
- INDV N/A
- QQQX 7.03%
- EPS Growth
- INDV N/A
- QQQX N/A
- EPS
- INDV N/A
- QQQX N/A
- Revenue
- INDV $1,170,000,000.00
- QQQX N/A
- Revenue This Year
- INDV N/A
- QQQX N/A
- Revenue Next Year
- INDV $3.00
- QQQX N/A
- P/E Ratio
- INDV N/A
- QQQX N/A
- Revenue Growth
- INDV 4.09
- QQQX N/A
- 52 Week Low
- INDV $7.33
- QQQX $20.27
- 52 Week High
- INDV $18.50
- QQQX $25.99
- Technical
- Relative Strength Index (RSI)
- INDV 64.75
- QQQX 64.63
- Support Level
- INDV $11.08
- QQQX $24.83
- Resistance Level
- INDV $12.98
- QQQX $25.32
- Average True Range (ATR)
- INDV 0.38
- QQQX 0.26
- MACD
- INDV 0.08
- QQQX 0.01
- Stochastic Oscillator
- INDV 77.91
- QQQX 97.80
About INDV Indivior PLC
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek an attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.